Comparison and Analysis of Blood Loss Formulas

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-01

Study Completion Date

2018-08-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Although it has been pointed that estimates are significantly inexact and different from each other, the actual accuracy of them has not been properly investigated and compared.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of Histological Samples From Patients With Hereditary Haemorrhagic Telangiectasia

NCT00733655

Telangiectasia, Hereditary Hemorrhagic

COMPLETED

Prevalence and Risk Factor of NP in Women With LUTS

NCT04104100

Lower Urinary Tract Symptoms

COMPLETED

Red Blood Cells as a Reflection of Endothelial Function in Old Age

NCT02265003

Red Blood Cells Endothelial Function Nitric Oxide Pool in Red Blood Cells and Blood Plasma

COMPLETED

Thromboelastography Normal Reference Values in China Hunan Province

NCT03146455

Coagulopathy Blood Transfusion Complication

COMPLETED

Investigation of Hemoglobin Oxygenation With Third Harmonic Generation Microscopy

NCT03619356

Hypoxia Oxygen Deficiency Tumor +1 more

ENROLLING_BY_INVITATION

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Blood Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hemoglobin content on blood loss

Hemoglobin content on blood loss, to assess ratio hemoglobin/volume.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Adults 18 - 90 yrs.

Exclusion Criteria

* Suspected or confirmed coagulopathy (including current treatment with anticoagulants or antiplatelet agents).
* Surgical blood loss volume \< 200 ml.
* Requirement for surgical gauzes during surgery, including conversion to open surgical techniques.
* Transfusion of red blood cells (RBCs) during the perioperative period.
* Significant postoperative bleeding (\> 50 ml in surgical drains) or any other type of significant blood loss.
* Fluid infusions or vasoactive drugs after the first 24 postoperative hours.

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No